Lafitte Ventures
Latest round
- Series A
Last raised
- Feb 2018
Total raised
- $48M
Investors
- 2
About Lafitte Ventures
Lafitte Ventures, Ltd.Founded in 2013 in Canada, Lafitte Ventures, Ltd. specializes in medical cannabis products.00 mn in an IPO on July 19, 2018, selling 9 million shares at USD 17 per share. In September 2019, it was acquired by Privateer Holdings, Inc. for an undisclosed amount, completing the transaction in December 2019.Tilray Medical offers a comprehensive range of pharmaceutical-grade cannabis products designed to meet the medical needs of patients. Their core product offerings include a variety of cannabis strains, extracts, and formulations tailored for specific medical conditions such as chronic pain, anxiety, and epilepsy. The company focuses on providing high-quality, standardized products that are rigorously tested for safety and efficacy, ensuring that healthcare providers and patients can rely on their effectiveness. Tilray's products are primarily sold in North America and Europe, with a significant emphasis on markets like Canada, Germany, and the United Kingdom.Tilray Medical generates revenue through direct sales of its medical cannabis products to healthcare providers and pharmacies, leveraging a B2B transaction structure. Their business model involves establishing partnerships with healthcare institutions and pharmacies to ensure a steady supply of their products to patients. Transactions typically occur on a per-order basis, with clients placing regular orders based on patient demand and inventory needs. Tilray's flagship products are positioned within various price tiers to accommodate a range of consumer needs, with specific pricing strategies reflecting the quality and therapeutic benefits of their offerings.Looking ahead, Lafitte Ventures, Ltd. plans to expand its product line with new cannabis formulations specifically designed for emerging medical conditions, with launches anticipated in the coming years. The company aims to enter additional international markets, including specific regions in Asia and Europe, by 2025.
Who invested in Lafitte Ventures
2 investors across 1 round
See all investors in Lafitte Ventures
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 7, 2018
Amount
$48M
Investors
Questions about Lafitte Ventures
Who invested in Lafitte Ventures?
Lafitte Ventures has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lafitte Ventures raised?
Lafitte Ventures has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lafitte Ventures last raise money?
Lafitte Ventures's most recent round on record is a Series A, in Feb 2018.
What does Lafitte Ventures do?
Lafitte Ventures is a healthcare company.
Where is Lafitte Ventures headquartered?
Lafitte Ventures is headquartered in Canada.
Which VCs invest in companies like Lafitte Ventures?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Lafitte Ventures's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Lafitte Ventures? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.